ARTICLE | Company News
Mirati Therapeutics cancer, infectious news
July 15, 2013 7:00 AM UTC
MethylGene Inc. completed its plans to reincorporate the company in the U.S. from Canada and change its name to Mirati. The biotech has applied to list its shares on NASDAQ and expects to start tradi...